About the Company
pavmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and efficiency. led by three accomplished medical device entrepreneurs and organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs, our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PAVM News
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call March 27, 2024 PAVmed Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PAVmed (PAVM – Research Report) and ...
New Strong Buy Stocks for March 27th
List today:Royal Caribbean Cruises Ltd. RCL: This cruise company has seen the Zacks Consensus Estimate for its current year ...
PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX
The incubator, PMX, and medical device firm Hatch Medical, execute joint venture agreement to complete their development and commercialization, starting with PortIO NEW YORK, March 21, 2024 ...
PAVmed Inc.: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio technologies Conference call and webcast to be held tomorrow, March 27 th at 8:30 AM ET NEW ...
PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips PAVmed (NASDAQ:PAVM) just reported results for the fourth quarter of ...
PAVmed (NASDAQ: PAVM)
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices ...
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary ...
PAVmed Inc. (1P50.F)
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ( ...
Q4 2023 PAVmed Inc Earnings Call
Ed Woo; Analyst; Ascendiant Capital Markets LLC Nick Sherwood; Analyst; Maxim Group LLC ...
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio technologies Conference call and webcast to be held tomorrow, March 27 th at 8:30 AM ET NEW ...
Loading the latest forecasts...